1. Home
  2. HWKN vs BEAM Comparison

HWKN vs BEAM Comparison

Compare HWKN & BEAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hawkins Inc.

HWKN

Hawkins Inc.

HOLD

Current Price

$139.60

Market Cap

3.0B

ML Signal

HOLD

Logo Beam Therapeutics Inc.

BEAM

Beam Therapeutics Inc.

HOLD

Current Price

$25.19

Market Cap

3.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HWKN
BEAM
Founded
1938
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Specialty Chemicals
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.0B
3.0B
IPO Year
1995
2019

Fundamental Metrics

Financial Performance
Metric
HWKN
BEAM
Price
$139.60
$25.19
Analyst Decision
Buy
Buy
Analyst Count
2
12
Target Price
$200.00
$50.75
AVG Volume (30 Days)
178.2K
2.6M
Earning Date
05-13-2026
05-06-2026
Dividend Yield
0.46%
N/A
EPS Growth
N/A
82.31
EPS
3.91
N/A
Revenue
$1,083,696,000.00
$24,000.00
Revenue This Year
$12.37
N/A
Revenue Next Year
$6.30
$33.77
P/E Ratio
$35.63
N/A
Revenue Growth
11.21
33.33
52 Week Low
$117.98
$15.60
52 Week High
$186.15
$38.26

Technical Indicators

Market Signals
Indicator
HWKN
BEAM
Relative Strength Index (RSI) 38.53 30.23
Support Level $130.08 $24.80
Resistance Level $152.94 $33.32
Average True Range (ATR) 5.11 1.99
MACD 0.67 -0.94
Stochastic Oscillator 38.85 1.83

Price Performance

Historical Comparison
HWKN
BEAM

About HWKN Hawkins Inc.

Hawkins Inc manufactures and sells a variety of chemicals and ingredients. The firm organizes itself into three segments based on the product type. The Industrial Solutions segment, provides industrial chemicals, products and services to industries such as industrial manufacturing, chemical processing, electronics, energy, plating, and surface finishing. The water treatment segment, which generates the majority of revenue sells chemicals and equipment used to treat potable water, municipal and industrial wastewater, industrial process water, and non-residential swimming pool water. Food and Health Sciences segment specializes in processing and formulation solutions as well as ingredient distribution to manufacturers in the nutrition, food, pharmaceutical, and agricultural markets.

About BEAM Beam Therapeutics Inc.

Beam Therapeutics Inc is a biotechnology company committed to creating a new class of precision genetic medicines based on its proprietary base editing technology, with a vision of providing lifelong cures to patients suffering from serious diseases. The company is focused on its programs in the hematology and genetic disease portfolios, which comprise different product candidates in its pipeline, such as BEAM-101, which is being developed to target Sickle Cell Disease, BEAM-302, a liver-targeting lipid nanoparticle, being developed to target Alpha-1 antitrypsin deficiency, and other drug candidates including BEAM-302, BEAM-103 & 104. The company operates and manages its business in one operating segment, United States.

Share on Social Networks: